当前位置:首页 - 行情中心 - 蔚蓝生物(603739) - 财务分析 - 现金流量表

蔚蓝生物

(603739)

  

流通市值:36.18亿  总市值:36.18亿
流通股本:2.53亿   总股本:2.53亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金394,950,690.681,367,328,858.391,049,571,792.13707,480,406.78
  收到的税费返还2,931,042.454,267,989.973,639,543.232,336,648.43
  收到其他与经营活动有关的现金7,649,391.3668,489,540.3135,065,700.0824,440,927.89
  经营活动现金流入小计405,531,124.491,440,086,388.671,088,277,035.44734,257,983.1
  购买商品、接受劳务支付的现金215,303,453.73719,269,484.34611,556,132.43415,825,838.35
  支付给职工以及为职工支付的现金76,564,018.33224,215,817.63178,534,315.16128,626,327.75
  支付的各项税费22,111,328.15109,454,156.4775,018,002.9750,432,510.79
  支付其他与经营活动有关的现金73,289,735.99273,199,448.84189,411,813.07129,247,674.68
  经营活动现金流出小计387,268,536.21,326,138,907.281,054,520,263.63724,132,351.57
  经营活动产生的现金流量净额18,262,588.29113,947,481.3933,756,771.8110,125,631.53
二、投资活动产生的现金流量:
  收回投资收到的现金11,073,189.59420,000--
  取得投资收益收到的现金-6,302,140.281,212,789.88558,896.79
  处置固定资产、无形资产和其他长期资产收回的现金净额-255,714.77398,570.39844.37
  处置子公司及其他营业单位收到的现金净额-2,456,090.91--
  收到的其他与投资活动有关的现金65,600,000915,604,858.96677,910,000562,880,000
  投资活动现金流入小计76,673,189.59925,038,804.92679,521,360.27563,439,741.16
  购建固定资产、无形资产和其他长期资产支付的现金14,770,042.9180,009,748.6243,685,575.4536,264,988.18
  投资支付的现金-437,500437,500437,500
  取得子公司及其他营业单位支付的现金-3,769,646.31--
  支付其他与投资活动有关的现金100,195,230915,416,815.12676,911,000520,280,000
  投资活动现金流出小计114,965,272.91999,633,710.05721,034,075.45556,982,488.18
  投资活动产生的现金流量净额-38,292,083.32-74,594,905.13-41,512,715.186,457,252.98
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,730,0001,580,000780,000
  其中:子公司吸收少数股东投资收到的现金-1,730,0001,580,000780,000
  取得借款收到的现金136,660,015.22752,993,029.39528,973,730.79365,687,913.25
  筹资活动现金流入小计136,660,015.22754,723,029.39530,553,730.79366,467,913.25
  偿还债务支付的现金121,184,343.31716,043,136.98500,087,262.88383,531,423.26
  分配股利、利润或偿付利息支付的现金13,005,518.2476,142,647.860,116,375.8254,756,913.84
  其中:子公司支付给少数股东的股利、利润9,300,00033,131,800.0322,571,800.0321,100,000
  筹资活动现金流出小计134,189,861.55792,185,784.78560,203,638.7438,288,337.1
  筹资活动产生的现金流量净额2,470,153.67-37,462,755.39-29,649,907.91-71,820,423.85
四、汇率变动对现金及现金等价物的影响--177,201.94--
五、现金及现金等价物净增加额-17,559,341.361,712,618.93-37,405,851.28-55,237,539.34
  加:期初现金及现金等价物余额235,039,077.25233,326,458.32233,326,458.32233,326,458.32
  期末现金及现金等价物余额217,479,735.89235,039,077.25195,920,607.04178,088,918.98
补充资料:
  净利润-97,465,510.65-39,804,417.47
  资产减值准备-6,525,877.88--860,799.97
  固定资产和投资性房地产折旧-106,485,295.2-50,304,782.76
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-106,485,295.2-50,304,782.76
  无形资产摊销-10,077,150.25-4,525,179.76
  长期待摊费用摊销-1,673,816.63-558,371.59
  处置固定资产、无形资产和其他长期资产的损失--470,744.93--393,279.13
  固定资产报废损失-26,858.73--
  公允价值变动损失--31,643,891.01--4,166,982.33
  财务费用-17,999,067.05-8,582,869.11
  投资损失-330,637.59-126,522.53
  递延所得税--6,642,788.16--3,595,388.71
  其中:递延所得税资产减少--6,564,512.19--4,538,589.18
    递延所得税负债增加--78,275.97-943,200.47
  存货的减少--43,944,416.95--34,651,439.93
  经营性应收项目的减少--47,542,220.91--24,674,637.59
  经营性应付项目的增加--9,191,770.93--28,394,707.89
  现金的期末余额-235,039,077.25-178,088,918.98
  减:现金的期初余额-233,326,458.32-233,326,458.32
  现金及现金等价物的净增加额-1,712,618.93--55,237,539.34
公告日期2026-04-252026-04-252025-10-292025-08-28
审计意见(境内)标准无保留意见
TOP↑